Glaxo Expects a Shot of Growth in 2013: CEO
February 06, 2013 at 12:28 PM EST
GlaxoSmithKline expects a return to growth in 2013 after the drugmaker's profits slipped in 2012 as austerity pricing in Europe continued to bite, CEO Andrew Witty told CNBC's "Squawk on the Street" on Wednesday.